Cancer's Cruel Economics - http://www.businessweek.com/magazin...
May 27, 2008
from
"It would have been the first new drug for prostate cancer in 20 years, and an outside panel of cancer experts chosen by the FDA recommended approval, but the agency asked for another clinical trial.". First new drug for prostate cancer in 20 years? That's not a lot of progress :(.
- Sanjeev Singh
"the death rate from cancer has dropped only about 7% in the past three decades" (or so the article claims)
- Sanjeev Singh